Reaching patients fast
Skip to content
Code of Ethics
Conflict of Interest
High Stakes Meetings
Health Technology Assessment
Brexit Transition Services
Post Authorisation Regulatory Services
Events & Presentations
What Do We Do?
Why Work At NDA?
A library of resources, factsheets and articles to broaden your knowledge.
Events & Presentations
Library News (54)
Community News (38)
Services News (23)
Events & Presentations (18)
Social News (9)
White Papers (6)
Health Technology Assessment (3)
Translational Science (3)
Regulatory Affairs (3)
HTA Advisory Board (2)
High-stakes Meeting Preparation (2)
Case Studies (1)
Regulatory Advisory Board (1)
Marketing Collaterals (1)
NDA welcomes EMA’s relocation to Amsterdam
Shelley Gandhi Chairs the 2nd Annual Biosimilars Europe Congress
We are expanding our geographic reach by opening an office in San Fransisco, California, USA
Join us at Europe CEO, Four Seasons, London
Free Webinar - The End Game: Payer Engagement
Meet us at PEGS Europe
Regulatory development and alignment between the USA and Europe
Shelley Gandhi presents on Signal Detection Management Throughout Products Life-Cycle
Brexit Impact - Are You ready?
NDAs Kaia Agarwal has been selected to join the distinguished 2017 class of RAPS Fellows
NDA Group appoints new Director of Biopharmaceuticals and ATMPs
NDA’s Brian Edwards speaks at the ISoP Latin American Chapter in Mexico
Meet NDA at Nordic Life Science Days 12-14 September
NDA Group appoints new Vice President for world renowned NDA Advisory Board
We are expanding our service offerings and geographic reach
When the pressure is high Prepare to Win
Have you ever wondered why compliance with regulations is so difficult?
Communicating with Payers
Are you aware of the key developments on the benefit-risk guidelines?
Novel Drug Movers and Shakers 2013-2016
Global Pharmacovigilance Regulatory Requirements: What’s New?
Maximising value in early development
Free Regulatory Webinar
Europe vs USA: new drug product approvals in 2016
Communicating for Approval and Market Access
The Premiere edition of Translational Science of Rare Diseases
NDA Group and PharmApprove Announce Merger
Senior Regulatory Affairs Consultant with Global Focus
Global Head of HR for leading life science consultancy
Dr. Lönngren co-authors articles on multi criteria decision analysis
Risk Evaluation and Mitigation Strategies - Feedback from GPvP seminar
NDA’s Prof. Thirstrup presents on Adaptive Pathways
Dr. Thomas Lönngren's article in 20 year anniversary EMA book
Brian Edwards speaks at the 8th Pharmacovigilance 2015
NDAs Brian Edwards co-authors chapter in “Medicines for Women”
NDA authors Mann’s Pharmacovigilance
Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation
State of US and Europe new drug product approvals in 2013
Drug Approvals Infographic
Steffen Thirstrup’s Pharmacology textbook
How should PV legislation impact your development plans for new medicines?
Adaptive licensing - How are regulators supporting innovation?
NDA Group at DIA Euromeeting 2014
Will real-world evidence make an impact in 2014?
Thomas Lönngren speaks at FT Biotechnology and Biosimilars Forum
How do we value drugs? Reforms for better decisions and use.
Thomas Lönngren 2013 IPS Medal Winner
Dr. Markku Toivonen talked at EURORDIS Summer School on Medical Research and Clinical Trial Methodology
Dr. Panos Tsintis shortlisted for TOPRA Lifetime Achievement Award